Price Chart

Historical Price Data

View and export this data back to 2020. Start Trial.
Date Open High Low Close Volume
Oct 30, 2026 3.69 3.76 3.585 3.65 1.730M
Oct 29, 2026 3.75 3.860 3.68 3.73 1.435M
Oct 28, 2026 3.69 3.77 3.65 3.71 946949.0
Oct 27, 2026 3.77 3.855 3.625 3.685 1.783M
Oct 26, 2026 3.67 3.865 3.64 3.66 3.332M
Oct 23, 2026 3.53 3.76 3.47 3.71 4.713M
Oct 22, 2026 3.40 3.63 3.395 3.60 2.399M
Oct 21, 2026 3.25 3.73 3.25 3.55 5.246M
Oct 20, 2026 3.00 3.359 3.00 3.26 2.638M
Oct 19, 2026 3.00 3.09 2.95 2.98 3.953M
Oct 16, 2026 3.14 3.14 2.905 2.94 4.855M
Oct 15, 2026 2.975 3.18 2.935 3.11 2.912M
Oct 14, 2026 2.87 2.96 2.82 2.87 3.151M
Oct 13, 2026 3.02 3.035 2.87 2.87 2.508M
Oct 12, 2026 3.25 3.27 3.10 3.12 3.266M
Oct 09, 2026 3.35 3.35 3.15 3.16 2.789M
Oct 08, 2026 3.34 3.39 3.16 3.32 2.173M
Oct 07, 2026 3.46 3.46 3.275 3.365 2.404M
Oct 06, 2026 3.53 3.54 3.285 3.46 2.200M
Oct 05, 2026 3.52 3.525 3.385 3.48 1.702M
Oct 02, 2026 3.57 3.64 3.46 3.56 4.886M
Oct 01, 2026 3.375 3.755 3.36 3.46 5.325M
Sep 30, 2026 3.51 3.925 3.46 3.69 4.803M
Sep 29, 2026 3.49 3.54 3.265 3.29 3.833M
Sep 28, 2026 3.27 3.620 3.21 3.53 3.484M

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Nicox SA 0.30
DBV Technologies SA 9.49
Cellectis SA 1.08
Genfit SA 9.43
Innate Pharma SA 1.46

Price Related Metrics

PS Ratio 14894.17
Price to Book Value 2.059
Earnings Yield -37.59%
Market Cap 862.42M